PNPO deficiency: An under diagnosed inborn error of pyridoxine metabolism

  • Morad Khayat
  • , Stanley H. Korman
  • , Pnina Frankel
  • , Zalman Weintraub
  • , Sylvia Hershckowitz
  • , Vered Fleisher Sheffer
  • , Mordechai Ben Elisha
  • , Ronald A. Wevers
  • , Tzipora C. Falik-Zaccai

Research output: Contribution to journalArticlepeer-review

52 Scopus citations

Abstract

The rare autosomal recessive disorder pyridoxine 5′-phosphate oxidase (PNPO) deficiency is a recently described cause of neonatal and infantile seizures. Clinical evaluation, and biochemical and genetic testing, were performed on a neonate with intractable seizures who did not respond to anticonvulsant drugs and pyridoxine. Sequencing of the PNPO gene revealed a novel homozygous c.284G>A transition in exon 3, resulting in arginine to histidine substitution and reduced activity of the PNPO mutant to 18% relative to the wild type. This finding enabled molecular prenatal diagnosis in a subsequent pregnancy, accurate genetic counseling in the large inbred family, and population screening.

Original languageEnglish
Pages (from-to)431-434
Number of pages4
JournalMolecular Genetics and Metabolism
Volume94
Issue number4
DOIs
StatePublished - Aug 2008
Externally publishedYes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • Neonatal seizures
  • PNPO deficiency
  • Pyridoxal phosphate (PLP)
  • Pyridoxamine
  • Pyridoxine 5′-phosphate oxidase (PNPO)

Fingerprint

Dive into the research topics of 'PNPO deficiency: An under diagnosed inborn error of pyridoxine metabolism'. Together they form a unique fingerprint.

Cite this